Table of Content


FIGURES AND TABLES
PART 1. INTRODUCTION
? Report description
? Objectives of the study
? Market segment
? Years considered for the report
? Currency
? Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
? Introduction
? Drivers
? Restraints
? Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY APPLICATION
? Chronic inflammatory demyelinating polyneuropathy (CIDP)
? Chronic lymphocytic leukemia
? Congenital HIV/AIDS
? Guillain-barre syndrome (GBS)
? Hypogammaglobulinemia
? Immune thrombocytopenic purpura (ITP)
? Immunodeficiency diseases
? Kawasaki disease
? Multifocal motor neuropathy (MMN)
? Myasthenia gravis
? Others
PART 6. MARKET BREAKDOWN BY END USER
? Homecare
? Hospitals & clinics
PART 7. KEY COMPANIES
? ADMA Biologics Inc.
? Biotest AG
? CSL Limited
? Grifols, S.A.
? Johnson & Johnson
? Kedrion Biopharma Inc. (Kedrion SpA)
? LFB S.A.
? Octapharma AG
? Takeda Pharmaceutical Company Limited
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER